Troches as an Alternative Delivery System for Peptide Therapy
As peptide-based therapies continue to expand across metabolic, hormone, and wellness-focused care, prescribers are increasingly evaluating delivery systems that balance efficacy, patient adherence, and clinical flexibility. While injectable peptides remain an important component of many protocols, troches have emerged as a valuable alternative delivery option for select patients and treatment goals.
Troches, also referred to as sublingual or buccal lozenges, are designed to dissolve slowly in the oral cavity, allowing medication to be absorbed through the mucosal tissue. This route of administration can bypass portions of gastrointestinal metabolism and provides a non-invasive option for patients who prefer to avoid injections. For prescribers, troches offer an additional tool that can be tailored to patient preference, tolerability, and lifestyle considerations.
From a clinical perspective, peptide troches may support improved adherence in patients who are injection-averse or inconsistent with self-administered injectable therapy. Troches allow for individualized dosing and gradual titration, making them suitable for maintenance protocols or patients requiring lower-dose, sustained exposure. Rather than replacing injectable peptides, troches function as a complementary option that broadens treatment flexibility.
At Restore Compounding Pharmacy, we work closely with prescribers to compound customized peptide troches that align with therapeutic intent and patient needs. Our pharmacists understand the formulation considerations specific to peptide stability, absorption, and consistency, ensuring each compound is prepared with accuracy and reproducibility. We collaborate directly with clinical teams to support dosing strategies, formulation adjustments, and continuity of care.
For clinicians seeking a reliable, service-oriented compounding pharmacy in Tampa and throughout Florida, Restore provides the clinical expertise, communication, and consistency necessary to support peptide therapy across multiple delivery modalities.
